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Climate change could threaten blood
supply by altering the distribution of
vector-borne disease: an Australian
case-study
Hilary J. Bambrick1,2,*, Rosalie E. Woodruff2 and
Ivan C. Hanigan2
1School of Medicine, University of Western Sydney, NSW, Australia; 2National Centre for
Epidemiology and Population Health, The Australian National University, Canberra, Australia
Background: Climate change is expected to promote more intense and prolonged outbreaks of vector-borne
disease, and alter the geographic boundaries of transmission. This has implications for the safety and supply
of fresh blood products around the world. In Australia, a recent outbreak of dengue fever caused a prolonged
regional shortage in the supply of fresh blood products.
Objective: To highlight the potential for climate change to affect the safety and supply of blood globally
through its impact on vector-borne disease, using the example of dengue in Australia as a case-study.
Design: We modelled geographic regions in Australia suitable for dengue transmission over the coming
century under four climate change scenarios, estimated changes to the population at risk and effect on blood
supply.
Results: Geographic regions with climates that are favourable to dengue transmission could expand to include
large population centres in a number of currently dengue-free regions in Australia and reduce blood supply
across several states.
Conclusion: Unless there is strong intergovernmental action on greenhouse gas reduction, there could be an
eight-fold increase in the number of people living in dengue prone regions in Australia by the end of the
century. Similar impacts will be experienced elsewhere and for other vector-borne diseases, with regions
currently on the margins of transmission zones most affected. Globally, climate change is likely to compound
existing problems of blood safety and supply in already endemic areas and cause future shortages in fresh
blood products through its impact on transmission of vector-borne disease.
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C
limate change over coming decades is expected to
have a number of adverse human health con-
sequences. In Australia, these impacts include
increases in the incidence of vector-borne disease and in
the size of geographic regions affected, as well as a greater
number of deaths and hospitalisations from heat expo-
sure and more cases of bacterial gastroenteritis (1).
A recent outbreak of dengue fever in the north of the
Australian state of Queensland highlights another prob-
able, but less direct, human health outcome with global
public health consequences: reduced availability of fresh
blood products due to more intense, more frequent and
more geographically widespread outbreaks of vector-
borne disease. Such events could exacerbate existing
shortfalls in blood supply and compromise transfusion
safety, especially in developing countries.
Dengue fever is caused by infection with one of four
serotypes of denguevirus. It is transmitted between humans
by the urban freshwater mosquito Aedes aegypti. Dengue
infection causes fever, general aches and occasional minor
bleeding. Subsequent infection with another of the dengue
serotypes can cause dengue haemorrhagic fever, a life-
threatening complication (2). Local transmission of dengue
occurs in most years in northern Queensland but the virus is
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not yet endemic in Australia. Instead, outbreaks commence
when a mosquito bites an infected traveller and transmits
the virus to a resident.
The transmission of dengue virus through blood
transfusion has been documented in Hong Kong (3)
and Singapore (4). It is neither known if other cases have
occurred, nor what level of viraemia causes infection (5),
but the potential risk to blood supplies in endemic
countries is high (6, 7).
The Australian Red Cross Blood Service (ARCBS)
collects blood across Australia from non-remunerated
volunteer donors. Approximately 26,000 blood donations
are required each week, or more than 1.35 million per
year (8). For Australia’s population of 22 million, this is
0.06 units used for each person per year. Currently there
is no screening test available for the dengue virus; red cells
and platelets collected in an outbreak area (or from
recent visitors to that region) cannot be used, even if
donated by an asymptomatic person as they may
unknowingly carry the virus. Plasma collected from
affected areas is still used for the manufacture of blood
products once it has been through the fractionation
process (Anthony Keller, ARCBS, personal communica-
tion).
From 1991 to 2007, there were 3,385 confirmed cases
of locally acquired dengue fever in Australia (9). On
average, there are 200 cases per year and another
estimated 120 sub-clinical cases (cases where symptoms
are minor and do not result in a consultation with a
general practitioner) (10), giving a ratio of clinical to sub-
clinical cases of approximately 1:0.6. There were five
deaths attributed to dengue during this period. Dengue
outbreaks in non-endemic regions like northern Australia
are sporadic; in some years case numbers are very high,
while other years may be free of cases.
Outbreaks have, however, become more regular in
recent years with five major and many smaller outbreaks
recorded between 1992 and 2004 (9). In contrast, the five
known outbreaks prior to 1992 occurred over a 90-year
period (11). Increasing international travel into north
Queensland and a global amplification in dengue activity
are proposed as principal reasons for this increase, and
sustained education and mosquito control programmes
instituted by public health authorities may have averted
what could have been even larger epidemics (Scott
Ritchie, Far North Queensland Health Service, personal
communication).
By 6 May 2009, more than 900 cases had been recorded
during the outbreak in Cairns and Townsville in northern
Queensland (with a likely additional 540 sub-clinical
cases) (Fig. 1). This caused a prolonged 14% reduction
in Queensland’s collection of red cells and platelets, as
deferral of donors resident in or who have visited the
region continued for several months. The outbreak
prompted the ARCBS to call for extra donations from
other parts of Queensland to ensure that demand for
blood supplies continued to be met (Anthony Keller,
personal communication). During an outbreak, the ban
on using fresh blood from affected areas remains in place
until there are no new cases for at least three months
(Anthony Keller, personal communication).
This is neither the first time a dengue outbreak has
caused a reduction in Queensland’s blood collections, and
nor will it be the last. We modelled changes to transmis-
sion-risk areas and estimated the population at risk of
dengue in the future to investigate whether associated
Fig. 1. Map of Australian States and Territories showing the location of the 2009 dengue outbreak centred around the towns of
Cairns and Townsville.
Hilary J. Bambrick et al.
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blood supply shortages may become more severe as a
result of climate change.
Methods
Regions at risk
We employed an empirical model of the relationship
between climate and dengue based on the known global
distribution of dengue (12). The climate factor that
predicts the presence of dengue most accurately is the
long-term average humidity of a region, expressed as
‘average annual vapour pressure’, which is an expression
of both humidity and temperature. Mosquito survival is
strongly dependent on moisture and humidity levels;
longer mosquito lifespans increase the likelihood of
multiple blood feeds and hence transmission of dengue.
Warmer temperatures also facilitate dengue transmission
through speeding up replication rate of the virus within
the vector, reducing the extrinsic incubation period and
thus time to infectivity. The model does not attempt to
predict the current or potential geographic range of the
vector itself, which may extend beyond regions where
virus transmission is currently observed.
We used this climatedisease relationship to model the
regions in Australia that are at high risk of becoming
suitable for dengue transmission under four different
climate change scenarios (Box 1). From annual average
vapour pressure and temperature baseline data for each
Statistical Division (SD) (13) for the period 19611990
(14), we calculated relative humidity by using standard
meteorological conversion formulae. We calculated the
probability that one (or more) epidemics of dengue fever
could occur, defining regions to be ‘at risk’ of dengue
where the model indicated a greater than 50% probability
of transmission.
Population at risk
We estimated the future population at risk using popula-
tion projections for each SD in the national census data
(16, 17). We obtained the estimates for the capital cities
and ‘rest-of-state’ areas for each State and Territory
between 2004 and 2100. The capital city estimates from
this dataset were used for the entire period; the rest-of-
state estimates were adjusted to reflect predicted trends in
the SDs within them. For this we used an earlier set of SD
population predictions from 2004 to 2019 (18) to inter-
polate SD populations from 2020 to 2049 to the
Australian Bureau of Statistics (ABS) estimate for 2050
(19, 20). In the absence of sub-state level projections from
the ABS from 2050 to 2100, we made the simplifying
assumption that the proportional contribution each SD
made to the rest-of-state totals up to 2050 would remain
for the rest of the century. On this basis, we estimated the
rest-of-state population totals for the period 2051 and
2100, taking the ABS 2100 values as the endpoint.
To estimate numbers of annual infections in the future,
a minimum expected average annual incidence of dengue
infection was derived from baseline using notifications
between 1991 and 2007 (10, (Scott Ritchie, Far North
Queensland Health Service, personal communication))
(i.e. not including the most recent and unusual 20082009
epidemic) and population resident in the at risk region.
An upper incidence estimate for future infections was
derived from numbers of infections during the most
recent outbreak (N.B. Even this upper estimate is
conservative as it does not take into account likely
changing transmission intensity in the future).
Effect on blood supply
We used the current proportions of ‘regular’ donors from
each state to estimate future percentage declines in
Box 1. Climate scenarios
The four climate scenarios used were produced by Australia’s Commonwealth Scientific and Industrial Research
Organisation (CSIRO) for the Australian Government’s Garnaut Climate Change Review (15).
Three of the scenarios assume ‘no action’ is taken to reduce emissions; emissions remain high and continue to rise,
mean global temperature increase is around 4.58C by 2100. These scenarios differ according to anticipated changes to
humidity and precipitation.
The fourth scenario assumes ‘strong action’ is taken; emissions are significantly reduced over coming decades, CO2
stabilises at 420 ppm by 2100, and mean global temperature increase is around 28C.
No action Strong action
Scenario 1 Hot and dry
2 Hot, median
humidity
3 Hot and
wet 4 Warm
Global average temperature increase (8C) 4.5 4.5 4.5 2
Humidity Low Median High Median
Climate change could threaten blood supply
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national blood supply based on modelled dengue trans-
mission areas, ‘population at risk’ and projected inci-
dence of infection. This current pattern of blood
donation by state was estimated from a recent national
survey of over 2,000 adults (methods described elsewhere
(21)) where response was ‘usually donate at least every six
months’.
Other public health and economic impacts
We estimated that the annual public health and health
care cost of dengue is approximately $2.82 per person
living in transmission-risk areas. This is comprised of:
. Surveillance and control: $2.56 per person, for vector
surveillance and control, health education, case ascer-
tainment and follow-up, and training of specialist staff
(Scott Ritchie, Far North Queensland Health Service,
personal communication).
. Diagnostic costs: 19c per person. Approximately three
times the number of diagnostic tests are conducted for
dengue and associated viruses as the number of
confirmed tests. Routine testing during the year might
results in another 50 tests being conducted  650 in all.
Approximately half these are PCR (@$75) and the
other half IgM ELISA (@$180) ((Scott Ritchie, Far
North Queensland Health Service, personal commu-
nication), (Russell Simmons, Queensland Health
Scientific Services, personal communication)).
. Treatment costs: 7c per person, from an average of two
visits to a general practitioner (one to seek a test, and
another to get the results) and additional follow-up
checks for approximately 10% of cases. A standard
Level B general practice consultation is $55. Assuming
all confirmed cases and 50% of unconfirmed cases
attend a general practice 2.1 times in an average year,
this makes 546 visits at baseline at a cost of
approximately $30,000 (Scott Ritchie, Far North
Queensland Health Service, personal communication).
. Hospital costs: Deaths to date have been rare and
generally occur before protracted hospital stays incur
notable system costs.
Time off work due to dengue illness or caring for a sick
child is an additional economic cost that we have
estimated previously (1) to be 0.005 days per year per
person living in a dengue transmission region.
Results
Regions at risk
Under each of the three ‘no emissions action’ scenarios,
there is an increase in the geographic spread and hence the
number of SDs that are favourable to dengue transmission
(Fig. 2). In Scenario 3 (Hot and wet), the geographic region
suitable for the transmission of dengue is expected to
extend far to the south and west from its current
distribution. The regions at risk include all coastal areas
of Queensland and into New South Wales, northern
Western Australia and the Northern Territory. In Scenar-
ios 1 (Hot and dry) and 2 (Hot, median humidity), dengue
Fig. 2. Areas suitable in Australia for dengue transmission in 2100 under four climate change scenarios (50% likelihood of
transmission).
Hilary J. Bambrick et al.
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transmission areas extend south in Queensland to include
Brisbane (and west to Mt Isa in Scenario 2), and into
Broome in Western Australia. In contrast, under emissions
mitigation (the ‘strong action’ Scenario 4 (Warm)), dengue
transmission-suitable areas remain limited to northern
Queensland and to Darwin.
Population at risk
The number of people at risk from dengue (i.e. the
population living in transmission-risk areas) estimated
under each scenario in coming decades is shown in Fig. 3,
and the percentage changes are represented in Table 1.
Annual rates of confirmed infection are estimated to be
between 47/100,000 and 230/100,000 in dengue suscep-
tible regions, with a further 28/100,000138/100,000 sub-
clinical infections likely. Table 2 shows the range estimate
for the number of people to be infected with dengue
based on the exposed population and these current rates
of infection. About 63% of these infections will be
‘clinical’ and require treatment.
The increase in number of people at risk and hence the
potential infections observed over the next four decades is
gradual and due solely to expected population growth in
existing dengue regions rather than to a geographic
expansion of transmission-suitable areas. Around mid-
century, however, step-changes occur under each of the
three ‘no action’ scenarios as a result of geographic
expansion incorporating new population centres. By the
end of the century, strong mitigation action could reduce
the number of people living in dengue transmission zones
in Australia by between 80 and 90%, depending on how
regional climates respond to increased carbon concentra-
tions (becoming dryer or wetter, respectively).
Effect on blood supply
The regional contributions to Australia’s blood supply,
estimated by current self-report of ‘regular’ donation and
the percentage of Australia’s population in each state and
territory is shown in Table 3. The estimated future
proportion of the state’s population living in transmis-
sion-risk areas in selected years is shown in Table 4.
As reduction in blood supply during an outbreak is
geographically determined, the proportion of the popula-
tion in each state living in transmission-risk zones relates
directly to the potential decline in blood supply in each
state during an outbreak (assuming that blood donors are
evenly distributed throughout the population of each
state). We estimated the percentage of donors in each
state that are likely to be at least periodically affected by
dengue outbreaks by multiplying the proportion of each
state’s population in transmission-risk zones by each
state’s percentage contribution to national blood supply
(Table 5).
Blood supply in the state of Queensland will be most
affected as it can expect declines of at least between 61
and 93% of its blood supply by the end of the century
(and at least 15% in the decades before then), which will
occur at least periodically if transmission patterns do not
intensify.
Other public health and economic impacts
Estimates of the average annual economic costs to public
health and surveillance are shown in Table 6 and
estimated annual number of work days lost are shown
in Table 7.
Discussion
In coming decades in Australia, the geographic regions
favouring dengue transmission are expected to expand
across a number of states and encompass new popula-
tions unless strong mitigation action is taken.
Fig. 3. The number of people living in regions in Australia at
high risk (50%) of dengue transmission under four climate
change scenarios. Scenarios: 1, Hot (dry); 2, Hot (median
humidity); 3, Hot (wet); 4, Warm (strong mitigation).
Table 1. Percentage change in numbers of people living in transmission-risk areas, selected years
Year Hot (dry) Hot (median) Hot (wet) Warm (strong mitigation)
2020 55 55 55 55
2050 114 114 114 114
2070 313 332 332 124
2100 1,500 1,680 2,500 133
Climate change could threaten blood supply
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If no or insignificant action is taken to reduce global
carbon emissions, the distribution of dengue transmis-
sion-suitable areas could, at the very least, progress
southward along the Queensland coast and include the
northernmost parts of Western Australia. If conditions
are wetter, transmission-suitable areas could extend into
New South Wales along the east coast, as far south as
Port Hedland in Western Australia and throughout the
Northern Territory. In terms of numbers of people
affected, up to eight times as many people could be at
risk compared to scenarios based on strong mitigation. If
several dengue outbreaks were to occur spontaneously in
different areas or spread between the newly transmission-
suitable regions, blood collections  and potentially the
supply of fresh blood products  could be greatly reduced
across Australia.
People living in towns and cities never before exposed
to dengue would be especially susceptible during out-
breaks. Large numbers of people could become infected,
increasing the amount of virus circulating in the popula-
tion and furthering risk of transmission. For example, in
1993, an estimated 26% of the population were infected in
one outbreak that occurred in the Queensland town of
Charters Towers (22).
The predictive model we employed to estimate changes
to dengue transmission regions is conservative. It predicts
current global dengue presence with an accuracy of 89%
based on areas deemed to have a greater than 50% chance
of transmission (12). This means that some regions
returning a lower than 50% probability estimate in the
model could still be suitable for dengue transmission, and
dengue will, on occasion, occur outside these areas. Such
is the case with Townsville which was affected by the
most recent Australian outbreak.
Importantly, this model does not predict vector dis-
tribution but rather regions suitable for future virus
transmission, based on current known transmission
regions. Vectors do exist, and have existed in the past,
in regions in Australia where transmission does not
currently occur (23). The model is thus influenced by
human behaviour, such as surveillance programmes that
have kept dengue from being more widespread in recent
years than it otherwise might be, and is informed by
current urban features and infrastructure. For example,
near universal water reticulation in non-remote areas
of Australia has reduced domestic storage and thus
A. aegypti breeding sites. Such behavioural factors and
infrastructure are not static; Beebe et al. have suggested
that human adaptation to climate change may cause
further spreading of the Aedes mosquito in Australia and
more intense epidemics as recent prolonged water
shortages have already, in some urban areas, led to the
re-installation of domestic water storage facilities (23).
The altered distribution of dengue modelled here is
predicted to reduce Queensland’s blood supply by
between 61 and 93% by the end of the century, unless
strong mitigation action is taken. Such reductions may
remain periodic, unless dengue becomes endemic to an
area. Although changing transmission intensity was not
modelled here, it is a likely outcome of climate change,
especially in regions that become more humid or where
minimum temperatures (night-time or winter-time) are
not sufficiently low to disrupt either vector activity or
replication of the virus (24). Again conservatively, we
estimate that blood supply in the Northern Territory
could be reduced by more than double the current
potential periodic loss, and Australia’s national supply
could be reduced by up to 20%. Larger reductions in
Table 2. Estimated annual numbers of new dengue infections under the four climate scenariosa
Year Hot (dry) Hot (median) Hot (wet) Warm (strong mitigation)
2020 3601,766 3601,766 3601,766 3601,766
2050 4952,429 4952,429 4952,429 4952,429
2070 9604,710 1,0054,931 9754,784 5252,576
2100 3,72018,253 4,14020,314 5,94829,182 5402,650
aUsing ‘population at risk’ projections (Fig. 3). Lower estimate is calculated from average annual incidence rate 19912007; upper
estimate is calculated from the much larger 20082009 outbreak.
Note. These upper estimates are likely to be conservative in a climate changed future as they do not consider changes to transmission
intensity or a shift from an epidemic to endemic pattern of disease.
Table 3. Australia’s blood donors by state/territory and
population distribution
State/Territory
Australia’s
‘regular’ donors (%)
Australian
population (%)
New South Wales 36.5 33.7
Victoria 22.1 24.8
Queensland 18.8 18.8
Western Australia 6.6 7.7
South Australia 10.4 9.9
Tasmania 1.7 2.4
Australian capital territory 2.7 1.0
Northern Territory 1.0 1.6
Hilary J. Bambrick et al.
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Queensland’s blood supply are likely to occur earlier than
modelled here as some years will most certainly experi-
ence outbreaks outside these boundaries.
Under all but the strong mitigation scenario, the
potential economic costs of dengue to Australia are
considerable; up to $22 million annual public health
costs in today’s terms, and 40,000 work days if transmis-
sion intensity remains unchanged. The costs of other
vector-borne disease not modelled here are also likely to
be affected by climate change in a similar manner.
We used costs from 2006 to 2008 and did not account
for any variation in costs over time. We assumed,
conservatively, that the cost per person will remain the
same in future, and that the pattern of dengue in
Australia will also remain the same (i.e. epidemic). If,
however, changing transmission patterns mean that
dengue becomes established in Australia, the associated
health system costs are likely to increase substantially
above our estimated baseline per person amount. First,
unlike the present, there would no longer be years with
few or even no cases of dengue recorded. Second, a much
larger campaign of mosquito eradication would be
needed across the endemic towns and cities. This would
involve trained personnel, broad scale and intensive
community education, and mosquito spraying. Currently
this work is only focused on ‘hot spots’  the local areas
Table 4. Proportion of the population within each dengue-risk state living in transmission areas under the four scenarios
Proportion of state/territory population living in dengue risk areas
Scenario State/Territory 2020 2050 2070 2100
Hot and dry Queensland 0.06 0.06 0.15 0.61
Western Australia   0.02 0.02
Northern Territory 0.46 0.46 0.46 0.46
Hot (median humidity) Queensland 0.06 0.06 0.15 0.69
Western Australia   0.02 0.02
Northern Territory 0.46 0.46 0.46 0.46
Hot and wet Queensland 0.06 0.06 0.15 0.93
Western Australia   0.02 0.04
Northern Territory 0.46 0.46 0.46 1.00
New South Wales    0.03
Strong mitigation Queensland 0.06 0.06 0.06 0.06
Northern Territory 0.46 0.46 0.46 0.46
Note: This proportion is extrapolated from the current pattern of residence and no allowances have been made for future contributions
from internal migration.
Table 5. Projected decline in blood supply in Australian States and Territories with high risk transmission regions, and
nationally
Decline in state’s blood supply
during an outbreak (%)
Total national decline in
blood supply (%)
Scenario State/Territory 2020 2050 2070 2100 2020 2050 2070 2100
Hot and dry Queensland 6 6 15 61 2 2 3 12
Western Australia   2 2
Northern Territory 46 46 46 46
Hot (median humidity) Queensland 6 6 15 69 2 2 3 14
Western Australia   2 2
Northern Territory 46 46 46 46
Hot and wet Queensland 6 6 15 93 2 2 3 20
Western Australia   2 4
Northern Territory 46 46 46 100
New South Wales    3
Strong mitigation Queensland 6 6 6 6 2 2 2 2
Northern Territory 46 46 46 46
Climate change could threaten blood supply
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(usually sections or suburbs) where cases have been
identified in a particular season.
We made no assumptions about future tourism pat-
terns and how these may affect the introduction of
dengue cases. At present, all outbreaks in Australia begin
with an infected person who enters from another country.
If tourism were to increase markedly (especially to and
from dengue-endemic countries), this might result in
more outbreaks in Australia. The opposite is also the
case. As well, the introduction of other serotypes of
dengue (and hence the risk of the more serious complica-
tion of dengue haemorrhagic disease) will also come from
residents returning or foreign tourists. This is a random
event, and we have not modelled the possible conse-
quences and costs involved.
Globally, the severity of dengue symptoms varies
enormously. Factors that affect disease severity include
ethnicity, age, nutritional status, the sequence of two
different dengue infections, the genotype of the infecting
virus, and the competence of the clinical and laboratory
surveillance systems. We assumed that Australia’s future
health system, demographic, social and environmental
influences on disease severity will broadly represent those
of today.
Currently, there are very few deaths due to dengue
fever in Australia (about 0.3 deaths per year). The
number of deaths from exposure to different dengue
serotypes is, however, likely to increase if dengue trans-
mission becomes more intense and the virus becomes
endemic as the risk of sustaining multiple infections in a
lifetime increases. We have assumed that the average
number of dengue haemorrhagic fever cases is not likely
to increase in future. Australian cases that occurred
between 2003 and 2004 were aged 3270 years, but in
Southeast Asia, dengue haemorrhagic fever predomi-
nantly occurs among children. A possible explanation for
the older age of patients in northern Queensland is the
long period between the dengue 1 and 2 epidemics in this
region, which means that only older people or those who
had been infected previously while overseas were suscep-
tible to dengue haemorrhagic fever. If outbreaks of
different dengue serotypes occur more frequently in
future (due to random chance, increased global virus
activity or higher tourism numbers), or if dengue became
established locally, this would probably change the
age profile of haemorrhagic fever towards younger
people (24).
Worldwide, the warmer temperatures associated with
climate change are expected to enhance transmission in
already affected areas and to increase the likelihood of its
emergence in new areas (25). Scenario-based modelling
using global climate models and average temperature
increases has consistently projected increases to the
latitudinal range of dengue transmission and increased
transmission intensity in already affected areas, and
predicts that the dengue virus will become established
in areas that are currently marginal for transmission. For
example, over the coming decades dengue is predicted to
spread into new areas further south in South America
and Africa as well as Australia (12, 24), further North
into the USA (12), while parts of India, the Middle East
and Southeast Asia classified as low risk will become high
risk (12). These models found that transmission intensity
is expected to increase not only in northern Australia, but
also across India and Thailand, eastern and northern
Africa, and in South and Central America. The epidemic
potential of dengue virus is expected to increase in a
number of major cities even with only a small increase in
average temperature (26, 27), and new patterns of year
Table 6. Average annual public health costs (millions $AUS) under the four scenarios for selected years, based on cost per
person living in regions at risk
Year Hot (dry) Hot (median) Hot (wet) Warm (strong mitigation)
2020 1.35 1.35 1.35 1.35
2050 1.87 1.87 1.87 1.87
2070 3.61 3.78 3.78 1.96
2100 13.99 15.57 22.36 2.04
Table 7. Average annual number of lost workdays under the four scenarios, based on days per person living in regions at risk
Year Hot (dry) Hot (median) Hot (wet) Warm (strong mitigation)
2020 2,400 2,400 2,400 2,400
2050 3,300 3,300 3,300 3,300
2070 6,400 6,700 6,700 3,500
2100 24,800 27,600 39,700 3,600
Hilary J. Bambrick et al.
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round transmission occurring in some regions, including
northern Australia (24).
The modelling of dengue and blood supply in Australia
thus highlights what is most certainly a global problem;
climate change induced blood shortages and impacts on
safety could become a significant and long-term issue,
especially in regions already struggling to control vector-
borne disease or those that are presently on the margins
of current disease distribution, and even more so in
countries which already struggle to meet their blood
supply needs. Such changes are probably already well
underway; the incidence of dengue is observed to be
increasing in parts of the Americas and Asia (28, 29).
The potential for climate change to reduce future blood
supply extends to a number of other vector-borne
pathogens. The transfusion-transmissibility of other vec-
tor-borne viruses of importance to Australia, including
Ross River virus, Barmah Forest virus and Murray Valley
Encephalitis is currently unknown (30). These viruses are
also expected to increase in incidence, intensity and
geographic distribution as conditions become more
favourable to mosquitoes and virus replication, a situa-
tion that could have further detrimental impacts on
Australian blood supply.
Climate change impacts could further contribute to
future blood shortages across the world as other globally
important vector-borne diseases are similarly affected.
While the modelling presented here examines average
trends across coming decades for a single virus, there is
considerable evidence that transmission of a number of
vector-borne diseases is already intensifying and expand-
ing geographically. For example, the recent emergence of
Chikungunya in northern Italy caused a reduction in
blood supply and plasma for manufacture (31), while this
and other vector-borne diseases such as West Nile virus
are becoming established in previously unaffected regions
(32, 33).
The increasing global movement of blood and blood
products adds another dimension to future blood safety;
transfusiontransmission risk is not geographically con-
tained in an already affected region and could potentially
lead to local transmission in a previously unaffected area,
while any contaminated supplies are becoming more
difficult to trace and recall.
In the modelling of future reductions in blood supply, a
possible change to the use of blood products was not
taken into account. The annual rate of IVIg use in
Australia has increased approximately 57% since 2003
and platelet use has increased approximately 13%, while
plasma-derived factor VIII and factor IX have declined in
favour of recombinant technology over the same period
(34). It is not possible to speculate reasonably on whether
the net therapeutic need for blood will increase or
decrease in coming decades.
By mid-century, rather than merely increasing the
frequency or amplitude of outbreaks in already affected
areas as seems to be occurring, the impact of climate
change on expanding dengue-transmission regions in
Australia will become obvious. By then, it is possible
that medical therapies will no longer rely on donated
blood, or that dengue has become a readily treatable or
curable infection, or that an accurate and reliable screen-
ing test has become available. The development of an
effective dengue vaccine and/or the future application of
pathogen reduction technology to blood components
may also mitigate the risks. However, there remain a
large number of other vector-borne pathogens, and
possibly some emerging ones, that will also be affected
by climate change. If the current situation for screening
and vaccination, and our reliance on blood products
holds for the future, we expect the safety and availability
of blood products around the world to be compromised
by climate change unless blood collections can be
adequately increased in non-affected areas. Other coun-
tries already intensely affected by dengue may experience
much earlier increases in the transmission range and
intensity of vector-borne disease than is expected for
Australia, and will be thus be subject to contemporary
medical technology and therapy.
With its national control of blood component inven-
tory, Australia is well prepared to be able to move blood
components into areas of need as required (Anthony
Keller, personal communication). Many other regions of
the world do not have such a safety net that can be
invoked when outbreaks occur, and with climate change
expected to affect a number of vector-borne infections
worldwide, periodic or even continuous shortfalls in
blood supply should be expected and planned for.
Climate in Australia and elsewhere over coming
decades will be shaped by future global carbon emissions.
The level of global emissions will be heavily dependent on
the action taken by national governments, especially
those of currently high polluting countries, such as
Australia, and those with large populations that are
rapidly industrialising, such as India and China.
While some climate change is ‘already in the pipeline’,
strong emission reductions are needed to avert global
average warming of greater than 28C, the threshold of
‘dangerous’ and irreversible climate change (35). It is
estimated that a 50% global reduction in emissions by
2050 is required in order to stabilise CO2 concentration
below 450 ppm and warming below 28C (35), equivalent
to the ‘strong mitigation’ scenario that was used here.
International action on emissions at this level could
help safeguard future blood supply around the world, as
demonstrated here for dengue transmission in Australia.
However, both the virus and the vectors are highly
sensitive to climate, thus even a much smaller increase
Climate change could threaten blood supply
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in global mean temperature will affect  and may already
be affecting  the transmission of vector-borne disease.
Importantly, and perhaps as demonstrated by the
recent epidemic of dengue in Australia, outbreaks of
vector-borne disease will become more difficult to control
as the climate changes. Regions that are currently under
disease surveillance may need to expand rapidly and
control measures implemented swiftly. Regulatory action
to reduce potential breeding habitats should be consid-
ered well in advance, such as adequate screening of water
tanks to inhibit oviposition by mosquitoes, even if global
warming is kept to a minimum by strong emission
reductions.
It is difficult when assessing the impacts of climate
change on any health outcome to predict precise changes
in occurrence or distribution. This is especially true for
vector-borne diseases, where innumerable environmental,
human and other animal behaviours and physiologies are
affected (36). The example presented here of how climate
change could affect the supply of blood in Australia by
extending the range of dengue-favourable environments
illustrates what should be a global concern, and high-
lights the importance of considering what may be a less
obvious climate impact on health.
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